Metraipolis › archive › dc_850b960647ea
Exceptional 106-month survival in multiply relapsed small cell lung cancer after sequential anlotinib and short-course sintilimab: a case report — Europe PMC PMID:42780552
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42780552
- DOI
- 10.3389/fonc.2026.1902026
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-15T22:12:38.560Z
- SHA-256 of the archived text
efb8a6831a7a1e12ccd9b1290fceb6972b5ce2fb0757c9c6bc9e2facb6c6628b- Stable URL of this page
https://metraipolis.com/documento/dc_850b960647ea
How to cite
Exceptional 106-month survival in multiply relapsed small cell lung cancer after sequential anlotinib and short-course sintilimab: a case report — Europe PMC PMID:42780552 — Europe PMC (en), https://europepmc.org/article/MED/42780552 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_850b960647ea (Metraipolis archive dc_850b960647ea, sha256 efb8a6831a7a1e12ccd9b1290fceb6972b5ce2fb0757c9c6bc9e2facb6c6628b)
BibTeX
@misc{dc850b960647ea,
title = {Exceptional 106-month survival in multiply relapsed small cell lung cancer after sequential anlotinib and short-course sintilimab: a case report — Europe PMC PMID:42780552},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42780552},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_850b960647ea; sha256 efb8a6831a7a1e12ccd9b1290fceb6972b5ce2fb0757c9c6bc9e2facb6c6628b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42780552. Agents can read the archived copy with the MCP tool read_document.